Bolt Biotherapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G. 

CEO
Randall C. Schatzman
CEORandall C. Schatzman
Employees
91
Employees91
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
91
Employees91

BOLT Key Statistics

Market cap
57.22M
Market cap57.22M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
118.11K
Average volume118.11K
High today
$1.54
High today$1.54
Low today
$1.47
Low today$1.47
Open price
$1.50
Open price$1.50
Volume
49.26K
Volume49.26K
52 Week high
$14.18
52 Week high$14.18
52 Week low
$1.39
52 Week low$1.39

BOLT Earnings

-$1.14
-$0.76
-$0.38
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.